A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
Clinical trial NCT05013424 · COMPLETED
Trial details
- NCT number
- NCT05013424
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2022-07-07
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.